AU2003276982A1 - Phenylalkylamines and pyridylalkylamines with serotoninergic receptor affinity - Google Patents

Phenylalkylamines and pyridylalkylamines with serotoninergic receptor affinity

Info

Publication number
AU2003276982A1
AU2003276982A1 AU2003276982A AU2003276982A AU2003276982A1 AU 2003276982 A1 AU2003276982 A1 AU 2003276982A1 AU 2003276982 A AU2003276982 A AU 2003276982A AU 2003276982 A AU2003276982 A AU 2003276982A AU 2003276982 A1 AU2003276982 A1 AU 2003276982A1
Authority
AU
Australia
Prior art keywords
pyridylalkylamines
phenylalkylamines
receptor affinity
serotoninergic receptor
serotoninergic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003276982A
Other versions
AU2003276982A8 (en
Inventor
Luciano Guarneri
Amedeo Leonardi
Gianni Motta
Carlo Riva
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Recordati SA
Original Assignee
Recordati SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Recordati SA filed Critical Recordati SA
Publication of AU2003276982A1 publication Critical patent/AU2003276982A1/en
Publication of AU2003276982A8 publication Critical patent/AU2003276982A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
    • C07D211/14—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AU2003276982A 2002-06-14 2003-06-16 Phenylalkylamines and pyridylalkylamines with serotoninergic receptor affinity Abandoned AU2003276982A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT2002MI001329A ITMI20021329A1 (en) 2002-06-14 2002-06-14 NEW OXIALYKYLAMES REPLACED
ITMI2002A001329 2002-06-14
PCT/EP2003/006290 WO2003106421A2 (en) 2002-06-14 2003-06-16 Phenylalkylamines and pyridylalkylamines

Publications (2)

Publication Number Publication Date
AU2003276982A1 true AU2003276982A1 (en) 2003-12-31
AU2003276982A8 AU2003276982A8 (en) 2003-12-31

Family

ID=29727278

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003276982A Abandoned AU2003276982A1 (en) 2002-06-14 2003-06-16 Phenylalkylamines and pyridylalkylamines with serotoninergic receptor affinity

Country Status (4)

Country Link
AU (1) AU2003276982A1 (en)
IT (1) ITMI20021329A1 (en)
TW (1) TW200409632A (en)
WO (1) WO2003106421A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0957073A1 (en) 1998-05-12 1999-11-17 Schwarz Pharma Ag Novel derivatives of 3,3-diphenylpropylamines
DE10315917A1 (en) * 2003-04-08 2004-11-18 Schwarz Pharma Ag Highly pure bases of 3,3-diphenylpropylamine monoesters
WO2012030894A1 (en) 2010-09-01 2012-03-08 Ambit Biosciences Corporation Thienopyridine and thienopyrimidine compounds and methods of use thereof
EP2663553B1 (en) 2010-09-01 2015-08-26 Ambit Biosciences Corporation Quinoline and isoquinoline derivatives for use as jak modulators

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE671440A (en) *
CA2141810A1 (en) * 1992-08-05 1994-02-17 Ian A. Cliffe Amide derivatives
GB9304632D0 (en) * 1993-03-06 1993-04-21 Wyeth John & Brother Ltd Amide derivatives
GB9408872D0 (en) * 1994-05-03 1994-06-22 Zeneca Ltd Heterocyclic compounds
US5525600A (en) * 1994-11-28 1996-06-11 American Home Products Corporation (Thiophen-2-yl)-piperidin or tetrahydropyridin carboxamides
US5610164A (en) * 1996-07-24 1997-03-11 American Home Products Corporation (Thiophen-2-yl)-piperidin or tetrahydropyridin azabicyclocarboxamides
UA66370C2 (en) * 1997-12-16 2004-05-17 Lilly Co Eli Arylpiperazines having activity to setotonin 1 receptors
ES2181366T3 (en) * 1998-06-30 2003-02-16 Lilly Co Eli PIPERIDINE DERIVATIVES THAT HAVE EFFECTS ON SYSTEMS RELATED TO SEROTONIN.

Also Published As

Publication number Publication date
TW200409632A (en) 2004-06-16
WO2003106421A3 (en) 2004-06-17
WO2003106421A2 (en) 2003-12-24
AU2003276982A8 (en) 2003-12-31
ITMI20021329A1 (en) 2003-12-15

Similar Documents

Publication Publication Date Title
AU2002314433A1 (en) Ephrin-tie receptor materials and methods
AU2003213835A1 (en) Multiple-property composite beads and preparation and use thereof
AU2002347022A1 (en) Benzimidazols and indols as glucagon receptor antagonists/inverse agonisten
AU2003267728A1 (en) Cannabinoid receptor ligands and uses thereof
AU2003220205A1 (en) Ethanol-diesel fuel composition and methods thereof
AU2003261723A1 (en) Cxcr4 antagonist and use thereof
WO2004040000A9 (en) G protein coupled receptors and uses thereof
AU2003261974A1 (en) Amine compounds and use thereof
EP1746902A4 (en) Multi-lectin affinity chromatography and uses thereof
AU2003233887A1 (en) Polymers their preparation and uses
AU2003293644A1 (en) Moldings and preparation and uses thereof
AU2003239484A1 (en) Zooplankton enrichment with probionts and prebionts and uses thereof
AU2003228205A1 (en) Porous polymers: compositions and uses thereof
AU2003266815A1 (en) Immunoglobulin compositions and methods
AU2003296369A1 (en) Imminoamines and preparation thereof
AU2003271183A1 (en) Block copolymer and application thereof
AU2003292628A1 (en) Hinge device with temporary angle-setting function
WO2004003149A8 (en) Cngh0005 polypeptides, antibodies, compositions, methods and uses
AU2003276982A1 (en) Phenylalkylamines and pyridylalkylamines with serotoninergic receptor affinity
AU2003206014A1 (en) Neuropeptide receptor and uses thereof
AU2003281691A1 (en) Furoisoquinoline derivative and use thereof
AU2003231827A1 (en) Pseudo-tissues and uses thereof
AU2003248352A1 (en) PROCESSES AND INTERMEDIATES USEFUL IN PREPARING Beta3-ADRENERGIC RECEPTOR AGONISTS
AU2003302173A1 (en) Spirotetrathiocarbamates and spirooxothiocarbamates
AU2003300396A1 (en) Chemokine antagonists and uses thereof

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase